Direxion Daily S&P Biotech Bear 3X ETF | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (27)

Latest Posts

About This Stock More About This Stock
5 Leveraged/Inverse ETFs That Gained More Than 40% In Q3
Article By: Sweta Killa
Monday, October 2, 2023 3:00 PM EDT
The third quarter proved to be highly volatile and uncertain for the U.S. stock market. This has resulted in huge demand for leveraged or inverse-leveraged ETFs as these fetch outsized returns on quick market turns in a short span.
In this article: TMV, LABD, NRGU, MSOX, JETD
Read
Inverse ETFs Soar As Market Turns Sour
Article By: Sweta Killa
Wednesday, August 9, 2023 11:12 AM EDT
After an astounding rally, Wall Street has been caught in feeble trading in the past week, triggered by the U.S. credit rating downgrade and now bank downgrades.
In this article: SOXS, LABD, TECS, HIBS, GDXD
Read
5 Best Inverse-Leveraged ETFs Of February
Article By: Sweta Killa
Wednesday, March 1, 2023 1:25 PM EDT
For ETF investors bearish on equities for the near term, either of these products could make an interesting choice.
In this article: SDOW, SDP, LABD, NRGD, GDXD
Read
Stocks See Worst Day In 2 Years: Inverse ETFs Shine
Article By: Sweta Killa
Thursday, May 19, 2022 10:28 AM EDT
Wall Street logged in its worst day since the early months of the pandemic due to rounds of disappointing earnings from some of the major retailers, underscoring that inflation is hurting corporate profits.
In this article: UVXY, SQQQ, SOXS, LABD, FNGD, M, TGT, WMT
Read
5 Leveraged/Inverse ETFs Up More Than 15% In November
Article By: Sweta Killa
Thursday, December 2, 2021 12:17 AM EDT
Amid the volatility, leveraged and inverse-leveraged ETFs gained increased popularity as these fetched outsized returns on the quick market turns in a short span.
In this article: SOXL, LABD, BNKD, NRGD, CLDS
Read

Latest Tweets for $LABD

No tweets yet!

PARTNER HEADLINES